Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Terminal Care | 2 | 2020 | 56 | 1.120 |
Why?
|
Hospice Care | 1 | 2020 | 27 | 0.730 |
Why?
|
Home Care Services | 1 | 2020 | 79 | 0.680 |
Why?
|
Extracorporeal Membrane Oxygenation | 6 | 2016 | 302 | 0.640 |
Why?
|
Heart Transplantation | 6 | 2016 | 307 | 0.540 |
Why?
|
Infant, Newborn | 14 | 2023 | 2907 | 0.440 |
Why?
|
Coronary Care Units | 1 | 2012 | 8 | 0.440 |
Why?
|
Aspergillus | 1 | 2012 | 51 | 0.410 |
Why?
|
Continuity of Patient Care | 1 | 2012 | 64 | 0.410 |
Why?
|
Hospital Mortality | 6 | 2021 | 465 | 0.400 |
Why?
|
Aspergillosis | 1 | 2012 | 127 | 0.390 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2012 | 186 | 0.390 |
Why?
|
Gastrostomy | 1 | 2011 | 60 | 0.390 |
Why?
|
Adrenal Insufficiency | 1 | 2010 | 17 | 0.380 |
Why?
|
Cardiac Surgical Procedures | 2 | 2012 | 318 | 0.380 |
Why?
|
Norwood Procedures | 1 | 2011 | 57 | 0.380 |
Why?
|
Quality of Health Care | 1 | 2012 | 222 | 0.370 |
Why?
|
Postoperative Complications | 3 | 2012 | 1033 | 0.370 |
Why?
|
Cardiopulmonary Bypass | 1 | 2010 | 97 | 0.360 |
Why?
|
Preoperative Care | 1 | 2011 | 184 | 0.360 |
Why?
|
Heart Diseases | 1 | 2012 | 237 | 0.350 |
Why?
|
Hemodynamics | 1 | 2010 | 290 | 0.340 |
Why?
|
Retrospective Studies | 16 | 2021 | 6432 | 0.330 |
Why?
|
Heart Defects, Congenital | 2 | 2012 | 608 | 0.310 |
Why?
|
Child | 14 | 2021 | 7341 | 0.310 |
Why?
|
Child, Preschool | 13 | 2021 | 4147 | 0.300 |
Why?
|
Infant | 12 | 2021 | 3817 | 0.290 |
Why?
|
Palliative Care | 2 | 2020 | 188 | 0.290 |
Why?
|
Heart-Assist Devices | 3 | 2016 | 147 | 0.260 |
Why?
|
Down Syndrome | 2 | 2016 | 100 | 0.260 |
Why?
|
Tertiary Care Centers | 2 | 2017 | 83 | 0.250 |
Why?
|
Parkinson Disease | 2 | 2017 | 180 | 0.250 |
Why?
|
Nitric Oxide | 1 | 2006 | 298 | 0.240 |
Why?
|
Central Venous Catheters | 1 | 2023 | 31 | 0.230 |
Why?
|
Hypoplastic Left Heart Syndrome | 2 | 2016 | 97 | 0.220 |
Why?
|
Male | 19 | 2021 | 27334 | 0.210 |
Why?
|
Catheterization, Central Venous | 1 | 2023 | 98 | 0.210 |
Why?
|
Humans | 25 | 2023 | 54284 | 0.210 |
Why?
|
Female | 19 | 2021 | 28441 | 0.210 |
Why?
|
Treatment Outcome | 7 | 2016 | 5604 | 0.200 |
Why?
|
Inflammation | 1 | 2006 | 674 | 0.200 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2021 | 17 | 0.190 |
Why?
|
Respiration, Artificial | 2 | 2015 | 285 | 0.190 |
Why?
|
Adolescent | 9 | 2021 | 6897 | 0.190 |
Why?
|
Terminally Ill | 1 | 2020 | 16 | 0.190 |
Why?
|
Brain Diseases | 1 | 2021 | 87 | 0.190 |
Why?
|
Heart Failure | 2 | 2015 | 541 | 0.170 |
Why?
|
Arkansas | 4 | 2012 | 2100 | 0.170 |
Why?
|
Length of Stay | 2 | 2012 | 683 | 0.160 |
Why?
|
Risk Factors | 7 | 2017 | 3935 | 0.160 |
Why?
|
Critical Care | 1 | 2020 | 234 | 0.160 |
Why?
|
Dopamine Agonists | 1 | 2017 | 9 | 0.150 |
Why?
|
Hypokinesia | 1 | 2017 | 8 | 0.150 |
Why?
|
Waiting Lists | 1 | 2016 | 49 | 0.140 |
Why?
|
Time Factors | 3 | 2015 | 3213 | 0.140 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2017 | 179 | 0.140 |
Why?
|
Tracheostomy | 1 | 2016 | 81 | 0.140 |
Why?
|
Young Adult | 4 | 2014 | 4318 | 0.130 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2015 | 41 | 0.130 |
Why?
|
Acute-Phase Proteins | 1 | 2015 | 25 | 0.130 |
Why?
|
Heart Arrest | 1 | 2016 | 159 | 0.130 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2015 | 55 | 0.130 |
Why?
|
Dystonia | 1 | 2014 | 11 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 1 | 2015 | 95 | 0.120 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2015 | 191 | 0.120 |
Why?
|
Vena Cava, Inferior | 1 | 2013 | 78 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 2 | 2012 | 514 | 0.110 |
Why?
|
Parvoviridae Infections | 1 | 2012 | 20 | 0.110 |
Why?
|
Parvovirus B19, Human | 1 | 2012 | 17 | 0.110 |
Why?
|
Organizational Objectives | 1 | 2012 | 36 | 0.110 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2012 | 42 | 0.110 |
Why?
|
Intra-Abdominal Hypertension | 1 | 2012 | 8 | 0.110 |
Why?
|
Professional-Family Relations | 1 | 2012 | 49 | 0.110 |
Why?
|
Models, Organizational | 1 | 2012 | 65 | 0.110 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 64 | 0.110 |
Why?
|
Tachycardia, Ectopic Junctional | 1 | 2011 | 4 | 0.100 |
Why?
|
Isoantibodies | 1 | 2012 | 31 | 0.100 |
Why?
|
Myocarditis | 1 | 2012 | 44 | 0.100 |
Why?
|
DNA, Viral | 1 | 2012 | 142 | 0.100 |
Why?
|
HLA Antigens | 1 | 2012 | 55 | 0.100 |
Why?
|
Amiodarone | 1 | 2011 | 23 | 0.100 |
Why?
|
Health Care Surveys | 1 | 2012 | 195 | 0.100 |
Why?
|
Chromosome Deletion | 1 | 2012 | 150 | 0.100 |
Why?
|
Laparotomy | 1 | 2011 | 36 | 0.100 |
Why?
|
Fundoplication | 1 | 2011 | 21 | 0.100 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2011 | 87 | 0.100 |
Why?
|
Reproducibility of Results | 2 | 2017 | 1304 | 0.100 |
Why?
|
Tissue Donors | 1 | 2012 | 110 | 0.100 |
Why?
|
Proteasome Inhibitors | 1 | 2012 | 110 | 0.100 |
Why?
|
Boronic Acids | 1 | 2012 | 197 | 0.100 |
Why?
|
Pyrazines | 1 | 2012 | 203 | 0.100 |
Why?
|
Graft Rejection | 1 | 2012 | 161 | 0.100 |
Why?
|
Adrenal Cortex Function Tests | 1 | 2010 | 5 | 0.100 |
Why?
|
Comprehension | 1 | 2012 | 115 | 0.100 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2010 | 34 | 0.100 |
Why?
|
Telemedicine | 1 | 2017 | 449 | 0.090 |
Why?
|
Hospitals, Pediatric | 1 | 2012 | 272 | 0.090 |
Why?
|
Tetralogy of Fallot | 1 | 2011 | 94 | 0.090 |
Why?
|
Program Evaluation | 1 | 2012 | 374 | 0.090 |
Why?
|
Herpesviridae Infections | 1 | 2010 | 46 | 0.090 |
Why?
|
Patient Care Team | 1 | 2012 | 273 | 0.090 |
Why?
|
Hydrocortisone | 1 | 2010 | 124 | 0.090 |
Why?
|
Weight Gain | 1 | 2011 | 243 | 0.090 |
Why?
|
Patient Discharge | 1 | 2012 | 353 | 0.090 |
Why?
|
Chronic Disease | 1 | 2012 | 614 | 0.090 |
Why?
|
Registries | 1 | 2012 | 553 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1056 | 0.080 |
Why?
|
Wounds and Injuries | 1 | 2012 | 321 | 0.080 |
Why?
|
Laparoscopy | 1 | 2011 | 188 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 570 | 0.080 |
Why?
|
Attitude of Health Personnel | 1 | 2012 | 397 | 0.080 |
Why?
|
Aged | 4 | 2017 | 10054 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2012 | 403 | 0.080 |
Why?
|
Aged, 80 and over | 2 | 2014 | 3431 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2015 | 2387 | 0.080 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 1048 | 0.080 |
Why?
|
Critical Illness | 1 | 2010 | 344 | 0.070 |
Why?
|
Middle Aged | 4 | 2017 | 13088 | 0.070 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2006 | 83 | 0.070 |
Why?
|
Deep Brain Stimulation | 2 | 2017 | 48 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2006 | 114 | 0.070 |
Why?
|
Jugular Veins | 1 | 2023 | 35 | 0.060 |
Why?
|
Catheters, Indwelling | 1 | 2023 | 68 | 0.060 |
Why?
|
Necrosis | 1 | 2023 | 208 | 0.060 |
Why?
|
Edema | 1 | 2023 | 74 | 0.060 |
Why?
|
Survival Rate | 2 | 2016 | 951 | 0.050 |
Why?
|
Adult | 3 | 2014 | 14207 | 0.050 |
Why?
|
Incidence | 2 | 2016 | 1082 | 0.050 |
Why?
|
Hypoxia, Brain | 1 | 2021 | 15 | 0.050 |
Why?
|
Cerebral Infarction | 1 | 2021 | 32 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2021 | 167 | 0.050 |
Why?
|
Brain Edema | 1 | 2021 | 39 | 0.050 |
Why?
|
Cerebral Hemorrhage | 1 | 2021 | 102 | 0.050 |
Why?
|
Odds Ratio | 1 | 2021 | 604 | 0.040 |
Why?
|
Cohort Studies | 2 | 2015 | 1543 | 0.040 |
Why?
|
Logistic Models | 1 | 2021 | 995 | 0.040 |
Why?
|
Ohio | 1 | 2017 | 67 | 0.040 |
Why?
|
Subthalamic Nucleus | 1 | 2017 | 13 | 0.040 |
Why?
|
Hand | 1 | 2017 | 57 | 0.040 |
Why?
|
Movement | 1 | 2017 | 111 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2017 | 156 | 0.030 |
Why?
|
Age of Onset | 1 | 2015 | 117 | 0.030 |
Why?
|
Fibrinogen | 1 | 2015 | 37 | 0.030 |
Why?
|
Patient Selection | 1 | 2016 | 286 | 0.030 |
Why?
|
Pallidotomy | 1 | 2014 | 1 | 0.030 |
Why?
|
Survival Analysis | 1 | 2016 | 735 | 0.030 |
Why?
|
Time | 1 | 2014 | 36 | 0.030 |
Why?
|
Mitral Valve Insufficiency | 1 | 2015 | 63 | 0.030 |
Why?
|
Azygos Vein | 1 | 2013 | 12 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2015 | 159 | 0.030 |
Why?
|
Prevalence | 1 | 2017 | 1025 | 0.030 |
Why?
|
Coronary Circulation | 1 | 2013 | 62 | 0.030 |
Why?
|
Databases, Factual | 1 | 2016 | 684 | 0.030 |
Why?
|
Neurosurgical Procedures | 1 | 2014 | 120 | 0.030 |
Why?
|
Texas | 1 | 2012 | 160 | 0.030 |
Why?
|
Hospitalization | 1 | 2016 | 705 | 0.030 |
Why?
|
Peritoneal Dialysis | 1 | 2012 | 37 | 0.030 |
Why?
|
Postoperative Period | 1 | 2012 | 189 | 0.030 |
Why?
|
Morbidity | 1 | 2012 | 149 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 531 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2014 | 1084 | 0.020 |
Why?
|
Electrocardiography | 1 | 2012 | 290 | 0.020 |
Why?
|
Risk Assessment | 1 | 2015 | 1361 | 0.020 |
Why?
|
Heart | 1 | 2012 | 360 | 0.020 |
Why?
|
Myocardium | 1 | 2012 | 441 | 0.020 |
Why?
|
Disease Progression | 1 | 2012 | 913 | 0.020 |
Why?
|
Comorbidity | 1 | 2010 | 663 | 0.020 |
Why?
|
Sex Factors | 1 | 2010 | 767 | 0.020 |
Why?
|
Quality of Life | 1 | 2014 | 922 | 0.020 |
Why?
|
Prognosis | 1 | 2012 | 2118 | 0.020 |
Why?
|
Age Factors | 1 | 2010 | 1198 | 0.020 |
Why?
|
United States | 1 | 2012 | 5217 | 0.010 |
Why?
|